Fuxiang Su

Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy

Liying Hao, Jingyuan Li, Xi Zheng, 2022, Cardiovascular therapeutics.

Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes

Yang Li, Jie Shen, Daqing Zhang, 2015, Lipids in Health and Disease.

Associations of shift work and night work with risk of all-cause, cardiovascular and cancer mortality: a meta-analysis of cohort studies.

Fuxiang Su, Dinggui Huang, Zhiyong Yang, 2021, Sleep medicine.

The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2.

Wei Li, Ming Lei, Liying Hao, 2023, European journal of pharmacology.

Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes

Daqing Zhang, Yali Shen, Lulu Li, 2015, Lipids in Health and Disease.